A 38-year-old man diagnosed with stage 4 head and neck cancer has successfully undergone treatment at Fortis Hospital, Manesar, using targeted oral therapy. The patient, who was initially diagnosed with a tumor in his throat, had been experiencing symptoms such as difficulty swallowing and breathing. Upon further examination, the tumor was found to have spread to his lymph nodes, indicating an advanced stage of cancer.
The medical team at Fortis Hospital, led by Dr. Anil Mandrol, Consultant, Medical Oncology, decided to treat the patient using targeted oral therapy. This approach involves the use of oral medications that specifically target the cancer cells, reducing the harm to healthy cells. The therapy was tailored to the patient’s specific genetic profile, which was determined through advanced genetic testing.
The treatment consisted of a combination of oral medications, including a tyrosine kinase inhibitor, which helps to block the growth of cancer cells. The patient was also given supportive care to manage any side effects of the treatment. The medical team closely monitored the patient’s progress, adjusting the treatment plan as needed.
After several months of treatment, the patient showed significant improvement, with the tumor shrinking by over 70%. The patient’s symptoms also improved, and he was able to swallow and breathe more easily. The treatment was well-tolerated, with minimal side effects.
The success of the treatment is attributed to the targeted approach, which allowed the medical team to specifically target the cancer cells while minimizing harm to healthy cells. The use of advanced genetic testing also played a crucial role in determining the most effective treatment plan for the patient.
Dr. Mandrol noted that the case highlights the importance of personalized medicine in cancer treatment. “Targeted therapy has revolutionized the way we treat cancer,” he said. “By tailoring the treatment to the individual patient’s genetic profile, we can achieve better outcomes and improve the quality of life for our patients.”
The patient is now in remission, and his quality of life has significantly improved. The case serves as an example of the effectiveness of targeted oral therapy in treating advanced head and neck cancer, and highlights the importance of personalized medicine in cancer treatment. The medical team at Fortis Hospital, Manesar, continues to provide comprehensive care to patients with cancer, using the latest advancements in medical technology and treatment approaches.